1. Yang Long, Zhengze Lu, Ling Mei, Man Li, Kebai Ren, Xuhui Wang, Jiajing Tang, Zhirong Zhang, and Qin He*. Enhanced Melanoma-Targeted Therapy by “Fru-Blocked” Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles. Advanced Science, 2018, 5(11), 1800229.
2. Xingli Cun, Man Li, Shuying Wang, Yifei Wang, Jialing Wang, Zhengze Lu, Ruixin Yang, Xian Tang, Zhirong Zhang and Qin He*. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration. Nanoscale, 2018, 10, 9935–9948.
3. Zhengze Lu, Yang Long, Xingli Cun, Xuhui Wang, Jianping Li, Ling Mei, Yiliang Yang, Man Li, Zhirong Zhang and Qin He*. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale, 2018, 10, 9957–9970.
4. Man Li, Kairong Shi, Xian Tang, Jiaojie Wei, Xingli Cun, Xiaoxiao Chen, Qianwen Yu, Zhirong Zhang, Qin He⁎. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. European Journal of Pharmaceutical Sciences, 124 (2018) 240–248.
5. Man Li, Kairong Shi, Xian Tang, , Jiaojie Wei, , Xingli Cun, Yang Long, Zhirong Zhang , Qin He*. Synergistic tumor microenvironment targeting and blood–brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 14 (2018) 1833–1843.
6. Man Li, Yuting Yang, Jiaojie Wei, Xingli Cun, Zhengze Lu, Yue Qiu, Zhirong Zhang, Qin He*. Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells. Nanomedicine: Nanotechnology, Biology, and Medicine, 14 (2018) 2541–2550.
7. Ling Mei, Yayuan Liu, Jingdong Rao, Xian Tang, Man Li, Zhirong Zhang and Qin He*. Enhanced Tumor Retention Effect by Click Chemistry for Improved Cancer Immunochemotherapy. ACS Appl. Mater. Interfaces 2018, 10, 17582−17593.
8. Ling Mei, Jingdong Rao, Yayuan Liu, Man Li, Zhirong Zhang, Qin He*. Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes. Journal of Controlled Release, 2018, 292, 28, 67-77.
9. Sheng Yin, Chunyu Xia, Yashi Wang, Dandan Wan, Jingdong Rao, Xian Tang, Jiaojie Wei, Xuhui Wang, Man Li, Zhirong Zhang, Ji Liu⁎, Qin He*. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways. Journal of Controlled Release 288 (2018) 148–160.
10. Qianwen Yu, Yue Qiu, Xuhui Wang, Jiajing Tang, Yayuan Liu, Ling Mei, Man Li, Ming Yang, Li Tang, Huile Gao, Zhirong Zhang, Wenming Xu*, Qin He*. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model. International Journal of Pharmaceutics 546 (2018) 115–124.
11. Yue Qiu, Qianwen Yu, Yayuan Liu, Jiajing Tang, Xuhui Wang, Zhengze Lu, Zhuping Xu*, Qin He*. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy. Pharm Res (2018) 35: 130.
12. Xuhui Wang, Yue Qiu, Qianwen Yu, Hui Li, Xiaoxiao Chen, Man Li, Yang Long, Yayuan Liu, Libao Lu, Jiajing Tang, Zhirong Zhang, Qin He*. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity. International Journal of Pharmaceutics 536 (2018) 1–10.
13. Yang Wang, Sheng Yin, Li Zhang, Kairong Shi, Jiajing Tang, Zhirong Zhang, Qin He*. A tumor-activatable particle with antimetastatic potential in breast cancer via inhibiting the autophagy-dependent disassembly of focal adhesion. Biomaterials 168 (2018) 1-9.
您当前位置： 